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Abstract 
Stem cells hold great promise for regenerative medicine. In order to realize the potential 
of stem cell-based therapies, it is highly required to understand the basic mechanisms of 
stem cell regulation and transform such knowledge into medical applications. However, 
understanding stem cell regulations is still challenging due to technical difficulties in 
studying stem cell biology. The hair follicle is a continuously regenerating mini-organ, 
in which keratinocyte and melanocyte stem cells cooperate to achieve periodical cycles 
of pigmented hair formation. The mouse hair follicle provides an ideal model by which 
to investigate molecular basis of stem cell regulation as defective molecular regulation 
results in abnormal hair formation, a phenotype easily recognized by appearance. It has 
been widely appreciated that the regulation of these stem cells is mediated through the 
epithelial-mesenchymal interactions where a cluster of mesenchymal cells, known as 
the dermal papilla, plays a key role. Here we aim to establish a system manipulating 
genes in dermal papilla to identify genes involved in the stem cell regulation. To this 
end, the purpose of this study is to identify a promoter element permitting stable and 
specific dermal papilla transgene expression in mice. In this report, by integrating BAC 
transgenesis and transposon-meditated gene delivery systems, we establish a simple 
pipeline to identify a gene expression element enabling dermal papilla-specific genetic 
modifications. 
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1. Introduction 
The field of stem cell biology is of considerable interest to modern medicine. Stem cells 
have the potential to revolutionize the field as a whole by opening up avenues in 
regenerative medicine allowing the repair of tissue injuries beyond the capabilities of 
the body’s spontaneous regeneration. However, there is need for a better understanding 
of the underlying mechanisms regulating differentiation and proliferation in order to 
develop safe and efficient therapies.  
 
1.1 The hair follicle as a model to study the molecular basis of hair regeneration 
During mouse embryogenesis epithelial cells invaginate into the skin to form the hair 
follice1. As the invagination begins, mesenchymal cells located below the epithelial 
cells form a specialized cell cluster, known as a dermal condensate. The condensate 
eventually becomes enveloped by the forming follicular matrix and the condensate cells 
differentiate into the dermal papilla1. Once specified, these dermal papilla cells play a 
major role in controlling hair follicle morphogenesis as well as hair cycling by secreting 
various signaling factors3. As the hair follicle matures, two discrete populations of stem 
cells, which are responsible for producing follicular keratinocytes and melanocytes in 
subsequent hair cycles, emerge in the bulge2, a compartment in the upper part of the 
outer root sheet. Keratinocyte stem cells located in the bulge migrate to the follicular 
center inside the matrix and form the hair shaft1, 2. Hair pigmentation is supplied by a 
cluster of melanocyte stem cells located above the dermal papilla2. 
 
Once the hair follicle morphogenesis is completed, hair regenerative cycling is initiated3. 
The hair cycle is the periodical formation of hair in the hair follicle whereby old hairs 
are shed and replaced by younger ones. After the formation of the first hair during the 
follicle morphogenesis, the hair cycle starts from the regression phase, a process called 
catagen, whereby the lower parts of the follicular matrix undergo apoptosis resulting in 
shedding of the old hair. Subsequently, hair follicles enter the resting phase, a stage 
called telogen, where they are in a quiescent stage. At the end of the telogen phase the 
hair follicle re-enters the growing phase, called anagen. During anagen, various growth 
factors are secreted form the dermal papilla to stimulate proliferation and differentiation 
of keratinocytes and melanocyte stem cells, resulting in formation of new pigmented 
hairs. After this anagen phase is complete another catagen will follow and the hair coat 
will be continuously renewed3. 
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Integration of a functional genomics approach and subsequent phenotypical assessment 
of hair formation and regeneration provides a way to identify physiologically relevant 
genes involved in regulation of the hair follicle stem cells. Defects in coat formation, 
regeneration or pigmentation are all phenotypes which are readily assessed simply by 
inspecting the hair coat making the hair follicle a potentially very powerful tool for 
rapid functional screening of multiple genes affecting stem cell regulation. 
 
1.2 The dermal papilla plays a central role in coordinating stem cell activation and 
hair cycling.  
The dermal papilla cells in the mouse hair follicle are known to directly influence the 
morphology and formation the hair coat. It has been shown that dermal papilla cells are 
required in the follicle in order to initiate hair formation4 and that the number of cells 
present directly influences the size and shape of the hair. The central role of the dermal 
papilla cells in hair follicle regulation has been recently exemplified in the reports using 
the Corin expression system5, a system which allows a high degree of transgene 
expression in the dermal papilla, that ablation of -catenin expression in the dermal 
papilla results in the loss of hair regenerative functions in mice6. Dermal papilla 
-catenin has also been shown to effect coat pigmentation and its absence leads to 
abnormal pigmentation patterns7. Whereas the Corin promoter provides a valuable tool 
to explore molecular basis of dermal papilla regulation using a transgenesis approach, it 
is known that its promoter activity is not detectable during early stage of dermal papilla 
development. Therefore, it has been highly anticipated to identify an alternative 
promoter element that allows the expression of transgene in all stages of dermal papilla 
development. 
 
Given the crucial involvement of the dermal papilla in the generation and pigmentation 
of the mouse hair coat it is an attractive target for genetic manipulation due to changes 
having a negative impact on the keratinocyte or melanocyte stem cell regulatory 
pathways would also give rise to an easily observable phenotype in the formation of 
abnormal hair coating and/or pigmentation. This would provide an advantageous model 
allowing identification of important molecules involved in keratinocyte and/or 
melanocyte stem cell regulation simply through observing the hair coat abnormalities 
arising in genetically modified animals. 
 
1.3 BAC transgenesis as a tool to establish dermal papilla specific transgene 
expression 
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In order to use the dermal papilla for stem cell research it is necessary to establish a 
stable dermal papilla specific expression system. This would serve to prevent interfering 
expression of transgene constructs in tissues surrounding the hair follicle or elsewhere 
in the mouse body as is observed using the Corin5 system discussed above. Such an 
expression system would require a dermal papilla specific promoter but to this date 
reports on such promoters have been limited. In an attempt to identify a suitable 
candidate for such a specific promoter, a microarray analysis had been previously 
conducted in our lab (data not shown). One such candidate that we have identified is 
Prokr2, whose expression was confirmed to be confined to the dermal papilla 
throughout development. Therefore the Prokr2 gene represents a subject of further study 
to determine the effectiveness of this regulatory element in driving dermal papilla 
specific expression of transgene constructs.  
 
BAC transgenesis has previously been reported as an efficient tool to generate 
transgenic cell lines8. The approach utilizes a BAC construct carrying the gene of 
interest as well as ~100k base pairs of the upstream and downstream elements. BAC 
transgenesis carries several advantages over traditional plasmid transgenesis as it 
contains many of the regulatory elements present in the proximity of the gene of 
interest8. This assists in avoiding transcriptional silencing of the transgenic construct as 
well as allowing reporter gene expression which more closely resembles the normal 
expression patterns. Although BAC engineering can be a labor intensive process due to 
the size of the BAC making its purification and handling difficult, there are tools such 
as the RedET recombination system available to modify the BAC as desired. 
 
1.4 Recombineering as a tool to sequence specifically modify BAC DNA. 
To enable easy BAC modification the RedET recombineering system has been recently 
established. RedET recombination or recombineering allows insertion of fragments up 
to several thousand base pairs in length into a target site8. The recombination is based 
on homologous recombination and carried out using recombinases derived from phage 
lambda. These recombinases recognize homologous sequences flanking the insert and 
the corresponding sequences at the target site. They then catalyze a recombination 
reaction between the two and in doing so site specifically integrates the insert into the 
BAC vector. This allows for insertion in a sequence specific manner at virtually any 
location on a BAC simply through equipping the desired insert with flanking DNA 
sequences.  
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1.5 Transposon-gene delivery of Bacterial artificial chromosomes 
The sheer size of a bacterial artificial chromosome makes its intact integration into the 
chromosome almost impossible without a system mediating the integration. 
Transposable elements have previously been shown to allow the integration of very 
large DNA constructs into the human chromosome using PiggyBac (PB) or Sleeping 
Beauty (SB) transposon mediated insertion8. The process consists of introducing two 
transposon Inverted terminal repeat (ITR) sequences in the BAC backbone through the 
recombineering process outlined above. ITRs are transposase recognition sequences and 
once recognized the transposase cleaves the DNA at the outside end of the sequence and 
proceeds to integrate the DNA contained in between them at a new site. This allows 
integration of very large ITR carrying constructs inside cells expressing a compatible 
transposase which is easily accomplished through cotransfection or coelectroporation of 
an appropriate construct. The transposase targets the ITR sequences of the insert, 
cleaves it and then mediate its integration into the chromosome.    
1.6 Aim 
This paper aims at identifying a specific promoter element permitting stable and dermal 
papilla specific transgene expression in mice. To this end the paper reports the 
generation of a BAC vector, using RedET recombination, containing a functional 
GFP-reporter gene in direct succession of the start codon of the second exon of the 
Prokr2 gene. The vector has been harboring transposable elements consisting of the SB 
transposase Inverted Terminal Repeat (ITR) sequences integrated into the backbone of 
the vector. The paper also demonstrates evidence that these elements are functional by 
inserting the BAC vector into Human Embryonic Kidney (HEK) 293 cells lines as well 
as present data comparing insertion efficiencies between the PB and SB transposases. 
 
2. Materials and methods 
2.1 Cloning and ligation  
All cloning was conducted by digesting vectors and insert with the corresponding 
enzymes for 1h at optimum temperature followed by gel purification of desired 
fragments. All restriction enzymes used were supplied by New England biolabs. Gel 
purification was carried out using Fastgene gel purification kits. Ligation was carried 
out for 20 minutes at room temperature using Mighty Mix DNA ligation kit (Takara 
Bio) ligation mixtures. Transformation of TOP10 Escherichia coli cells was performed 
by thawing vials of competent Escherichia coli TOP10 (Invitrogen) on ice followed by 
the addition of 1ul of DNA solutions. The mixture was incubated on ice for 10 minutes 
followed by incubation at 42 degrees. After 45 seconds 1ml of SOC media was added to 
9 
 
the vial. Cells were selected on LB agar plates containing the appropriate antibiotics 
until colonies were large enough to allow harvesting. The insertions were verified by 
colony PCR. Purification of plasmids was carried out using either plasmid miniprep kits 
(Fastgene) or plasmid midi prep kits (QIAGEN) using high copy number protocols. 
 
2.2 Construction of vector pSL-Prokr5-EGFP-Pgk-neo-Prokr3 
DNA fragment containing eGFP-BGHpA was amplified by PCR from a 
pROSA26-mT/mG vector as a template using eGFP ApaI and eGFP SalI primers. The 
resulting PCR fragment was digested with ApaI and SalI and subcloned into 
pBS-FRT-pgk-neo-FRT vector. The vector backbone was later changed to that of 
pSL-1180 vector. Genomic fragments containing ~500bp of sequence homologous to the 
Prokr2 gene were amplified by PCR using Prokr2 SalI and Prokr2 ApaI primers as well 
as Prokr2 SacII and Prokr2 HindIII. The PCR products were digested with their 
corresponding enzymes and the DNA fragments were subcloned into 
pSL-eGFP-BGHpA-FRT-PGK-neo-FRT vector resulting in vector 
pSL-Prokr5-EGFP-Pgk-neo-Prokr3. Detailed vector maps and primer sequences are 
presented in the supplementary material. 
 
2.3 Verification of eGFP fluorescence 
Prokr5-EGFP fragment from vector pSL-Prokr5-EGFP-Pgk-neo-Prokr3 was cloned 
into vector pBK-CMV using SalI and KpnI. The vector was transfected into HEK293 
cell using FuGENE6 reagent (Invitrogen). Cells stocks frozen in -80˚C were thawed in a 
water bath followed by addition of the cell suspension into 10ml DMEM-glutamax 
medium (Gibco), supplemented with 10% FCS, 1x Anti-Anti (Gibco) and 1mM sodium 
pyruvate, to wash out the stock media. The cells were centrifuged for 5 min at 1200rpm 
and the media was removed before resuspension in the DMEM-glutamax, media 
supplemented as above, and cell counting. Cells were counted using a Buchner chamber 
and ~50000cells/well were added to 24 well plates. The cells were grown until ~80% 
confluence and the media was replaced followed by the addition of the of FuGENE 6 
reagent mixture. The mixture was prepared by mixing 200ng of vector and 1,8ul of 
FuGENE 6 reagent and diluting to 20ul using opti-MEME (Gibco) media. The mixture 
was incubated at room temperature for 15 min before addition to the culture. GFP 
fluorescence was detected by fluorescence microscopy after 24 hours. 
 
2.4 BAC engineering using RedET recombination 
BAC engineering was performed using the RedET recombination (Gene Bridges) kit. 
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Escherichia coli strains carrying Prokr2 BAC, provided by CHORI BACPAC resource 
center (Children's Hospital Oakland Research Institute, USA), were grown overnight in 
10ml of LB medium supplemented with chloramphenicol. 100ul of the overnight 
culture was used to inoculate 10ml LB medium supplemented with chloramphenicol 
and the culture was grown for 2 hours. 1,4ml of the culture was harvested by 
centrifugation and the cells were washed 3 times with ice cold water before 
resuspension into 50ul of the same ice cold water. 1ul of RedET plasmid solution was 
added and the suspension was moved to a 1mm electroporation cuvette (Bio-Rad). The 
cells were electroporated at 1350V 10μF and 600Ω followed by the immediate addition 
of 1ml of SOC media. The resulting cell suspension was incubated at 30 degrees for 70 
minutes before plating onto LB agar supplemented with chloramphenicol and 
tetracycline. The plates were incubated at 30˚C for two days. A single tetracycline 
resistant colony was picked and grown overnight at 30 ˚C in 10ml LB media 
supplemented with chloramphenicol and tetracycline. 100ul of the overnight culture was 
used to inoculate 10ml LB supplemented with chloramphenicol and tetracycline and the 
culture was grown for 3 hours at 30 ˚C followed by addition of arabinose to a 
concentration of 0.4% and incubation at 37 ˚C for 1h. The cells were induced for 1h 
after which 1.4 ml of the culture was harvested by centrifugation, washed 3 times with 
ice cold water and resuspended in 50ul of the same water. 1ul of DNA solution 
containing Prokr5-EGFP-Pgk-neo-Prokr3 fragment which was obtained from vector 
pSL-Prokr5-EGFP-Pgk-neo-Prokr3 by digestion with SalI and BsiWI was added to the 
cell suspension followed by electroporation using 1mm cuvettes (Bio-Rad) at 1350V 
10μF and 600Ω. 1ml of SOC media was added immediately after electroporation and 
the cells were incubated at 37 ˚C for 90 minutes followed by plating onto LB agar 
supplemented with chloramphenicol and kanamycin. The plates were incubated at 37 ˚C 
for two days. Successful recombination was verified by colony PCR using primers 
Prokr2 5’ Scr together with GFP genotyping to verify the 5’ integration and Prokr2 3’ 
Scr together with Neomycin genotyping to verify the 3’ end. Recombination of PB and 
SB ITR was carried out by retransforming the RedET plasmid and carrying out 
recombination as described above. The inserts carrying PB and sleeping beauty ITRs 
were isolated from vector pR6K-Hygro-Amp-PB for PB and pR6K-Hygro-Spec-SB for 
sleeping beauty by digestion with PacI and AscI followed by the addition of 1u of 
Shrimp alkaline phosphatase and incubation at 37 ˚C for 1h. The resulting selectable 
markers with flanking ITRs were purified using PCR cleanup kit. After the 90 minute 
incubation at 37 ˚C the cells were plated onto LB agar supplemented with 
chloramphenicol, kanamycin and ampicillin for cells recombinated with PB ITRs and 
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chloramphenicol, kanamycin and spectinomycin for cells recombinated with SB ITRs. 
The plates were incubated at 37 ˚C for 2 days. To purify the BAC a single colony 
carrying either ampicillin or spectinomycin resistance was grown overnight in 500ml of 
LB media supplemented with antibiotics as above. The BAC was prepared using 
QIAGEN plasmid midiprep kit according to low copy number plasmid protocols. The 
constructs were designated Prokr2-PB for the BAC carrying PB ITRs and Prokr2-SB 
for the corresponding BAC carrying SB ITRs. Primer sequences, detailed PCR 
protocols and vector maps are presented in supplementary material. 
 
2.5 Sequencing 
 
Sequencing was performed using M13 forward and reverse primers by DNA sequencing 
Core, Life Science Research Center, Gifu University according to sequencers 
specifications. 
 
2.6 Verification of Neomycin selection strategy by transfection of vector 
pMCS5-PB and pMCS5-SB 
PB and SB ITR carrying fragments from section 2.3 were cloned into vector pMCS5 
between PacI and AscI sites. The resulting vectors were designated pMCS5-PB for the 
vector carrying PB ITRs and pMCS5-SB for the corresponding vector carrying SB ITRs. 
The vectors were transfected into HEK293 cells as described above with the exception 
of 200ng of transposase gene coding vector pCMV-hyPBase for PB or pC-SB100XN-pA 
for Sleeping Beauty being cotransfected with 600ng of DNA pMCS5-pB or pMCS5-SB 
together with a FuGene reagent volume of 3ul/ug DNA. The mixture was also diluted to 
100ul as compared to 20 using opti-MEME (Gibco) media. 24 hours after transfection 
the growth media was removed and the cells were dissociated through addition of 200ul 
of Tryple express (Gibco) trypsin containing media directly into the well. The cells were 
incubated for 5 min at 37 degrees to allow for complete dissociation before harvest. 
Harvested cells were washed with 10ml DMEM-glutamax media, supplemented as 
above, before centrifugation for 5 min at 1200 rpm. The cells were then resuspended in 
4ml of the same media and plated onto 6cm dishes. Geneticin (Gibco) was added the 
following day to a final concentration of 1mg/ml and the plates were incubated for 2 
weeks with weekly media changes.  
 
2.7 Transfection of vector Prokr2-PB and Prokr2-SB into HEK293 cells 
BAC transfection was carried out as described in 2.5 using 600ng of BAC DNA. After 
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neomycin selection the media was removed and 4ml of PBS buffer (pH 7.2) was added 
and surviving cells were picked up using pipette and transferred to a 96 well plate 
containing 30ul of Tryple express (Gibco) trypsin containing media and incubated for 5 
minutes at 37 degrees before addition of an equal volume of DMEM-glutamax media, 
supplemented as above, in order to inactivate the trypsin. The dissociated cells were 
moved to 48 well plates and 200ul of glutamax media was added. The cells were left to 
grow until ~80% confluence before genomic DNA extraction. 
 
2.8 Preparation of genomic DNA from transfected 293 cells 
Genomic DNA was harvested from HEK293 cells using lysis buffer consisting of 10 
mM Tris pH 8.4, 50 mM KCl, 2 mM MgCl2, 0.45% NP-40, 0.45% Tween 20 and 50 
ug/ml Proteinase K. The growth media was removed and the lysis buffer was added 
directly to the wells before incubation at 37 degrees for 5 minutes. The lysate was 
harvested and incubated for 1h at 55 ˚C followed by 45 min at 95 ˚C to inactivate 
proteinase K. 
 
2.9 Genotyping of genomic DNA from HEK293 cells transfected with either 
Prokr2-PB or Prokr2-SB 
Genomic DNA preparations from section 2.8 were used for genotyping PCR at a ratio of 
1ul to 20ul of PCR reaction mixture. PCRs were conducted to amplify amplicons of 
~450bp directly upstream of the eGFP reporter gene and ~400bp directly downstream 
of the Neomycin resistance cassette using primers Prokr2 5’ SalI and Prokr2 5’ ApaI 
primers and Prokr2 3’ SacII and Prokr2 3’ HindIII primers. A ~800bp amplicon 
consisting of ~350bp eGFP gene sequence as well as ~450bp upstream sequence was 
amplified using GFP genotyping and Prokr2 SalI primers. Internal control reactions 
were conducted by amplifying a ~800bp fragment from the AAVS1 site of the human 
genome using AAVS15 and AAVS13 primers. Detailed PCR protocols and primer 
sequences are presented in supplementary material. 
 
2.9 Staining of HEK293 cell cultures 
HEK293 cell staining was performed by washing the cells twice using 4ml of PBS 
media followed by the addition of 3ml 4% Paraformaldehyde 5min incubation a 37 
degrees followed by 2 times washing with 4ml PBS and the addition of 1ml Meyer 
hematoxylin solution. The mixture was incubated for 5 min at 37 ˚C before removal of 
the hematoxylin solution.  
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3. Results 
3.1 Construction of recombineering constructs 
In this study, we modified a bacterial artificial chromosome (BAC) vector 
(RP23-33N15) containing a genomic region of the Prokr2 gene to generate a Prokr2 
promoter reporter construct. To this end, we constructed a plasmid vector containing an 
enhanced green fluorescent protein (eGFP) reporter cassette, in which DNA fragments 
encoding an eGFP gene followed by a polyadenylation sequence and a selectable 
marker were assembled. This cassette was further flanked by ~450bp sequences 
homologous to the Prokr2 gene to allow insertion of the eGFP reporter cassette directly 
after the initiating methionine (ATG) in the second exon of Prokr2 using BAC 
recombineering technology (see Fig 1). As a selection maker, a FRT-PGK-gb2-neo-FRT 
cassette was designed to allow neomycin/kanamycin selection in prokaryotic and 
eukaryotic cells. A schematic of the fragment is presented in Fig 1. Detailed procedures 
for the vector construction are described in Materials and Methods. 
 
Fig 1: Schematic drawing of fragment used for recombineering. The reporter gene 
(GFP) is followed by a BGHpA polyadenylation sequence and a selectable marker, 
surrounded by FRT elements, under the control of a PGK promoter. GFP and the 
selectable marker are flanked by homologous sequences to the Prokr2 gene. 
 
 
3.2 Verification of eGFP fluorescence 
In order to verify the integrity of the eGFP reporter gene fragment, the eGFP gene was 
subcloned into a mammalian expression vector, pBK-CMV to examine eGFP 
fluorescence in HEK293 cells. The pBK-CMV vector contains the SV40 promoter 
element which allows for efficient expression in human cell lines. It was confirmed by 
the results that the eGFP gene was functional and that the cloning in front of the Prokr2 
start codon was successful and in frame (see Fig 2). The DNA sequence of the eGFP 
gene including the initiation codon was further confirmed by direct DNA sequencing.  
PGK Neo  
FRT
BGHpAEGFP Prokr2 Prokr2
FRT
ATG
14 
 
 
Fig 2 GFP fluorescence, detected after 24 hours, of HEK293 cells transfected with 
pBK-CMV-GFP (left) and pBK-CMV-Prokr2-GFP (right). Bright spots represent 
individual HEK293 cells expressing the GFP reporter gene. 
 
3.3 Construction of BAC vector 
Following the functional verification of the eGFP reporter gene, the reporter cassette 
was integrated in the BAC vector harboring Prokr2 genomic sequence using 
recombineering (see Fig 3) 
 
Fig 3: Schematic of the recombination between the Prokr5-EGFP-Pgk-neo-Prokr3 
and the Prokr2 gene region of the BAC vector. The recombination inserts the 
fragment in between the homologous regions in the second exon whereby the ATG of 
the eGFP replaces the ATG of Prokr2 as to avoid frame shifts. The primers used for 
colony PCR verification are marked as arrows with green representing GFP genotyping 
and grey representing Neomycin genotyping primers. Prokr2 5’ Scr and Prokr2 3’ Scr 
are black and located outside the recombinated fragments in the 5’ and 3’ direction 
respectively. 
 
As shown in Fig. 4, the insertion of eGFP reporter cassette was verified by colony PCR. 
The expected band lengths for a recombination which took place at the intended site 
were ~800 for the 5’ end and ~1400 for the 3’ end. Based on the results we concluded 
that 1 transformant had the correct insertion of the eGFP-BGHpA-FRT-PGK-neo-FRT 
  
Exon 1 Intron 1 Exon 2 
ATG 
ATG 
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fragment as indicated by the presence of bands of the expected size in the wells loaded 
with reactions amplifying the 3’ and 5’ end of the fragment. Three transformants were 
found to carry the neomycin resistance cassette fragment while lacking the reporter gene 
insertion. The 4 transformants were found to contain no insert as no PCR product was 
detectable. 
 
 
     
 
 
Fig 4: Colony PCR reactions of Prokr2 BAC carrying Escherichia coli strain after 
recombination with Prokr2-eGFP-bpA-NeoR-Prokr2 fragment. Samples loaded in 
the wells: 1, Ladder 1(supplementary material), 3’ and 5’ colony PCR reactions for 
transformants 1-8. The colony number is indicated above the forks and the location of 
the amplicon is shown at the end of the fork respectively. 
 
To facilitate transposon-mediated BAC insertion, Prokr2 BAC was further modified to 
insert a PB ITRs cassette into the BAC backbone. To facilitate stable recombination, the 
PB ITRs flanking an ampicillin resistance cassette was recombined into a LoxP site of 
the BAC using recombineering (Prokr2-PB). We also constructed a BAC construct 
harboring SB ITRs using the same approach with the exception of the flanked resistance 
cassette being spectinomycin (Prokr2-SB). A single colony carrying either ampicillin 
resistance or spectinomycin resistance was picked up and the BAC was purified for 
further functional validation. 
 
3.4 Verification of neomycin selection strategy 
Before integration of BAC constructs into the genome of HEK293 cells we verified if 
an element flanked by PB or SB ITRs was successfully integrated into the host genome. 
HEK 293 cells were transfected with pMCS5-PB (see Materials and Methods) along 
8 76543 21 
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with pCMV-hyPBase vector (expressing PB transposase). For SB ITRs validation, 
pMCS5-PB (see Materials and Methods) and pC-SB100XN-pA vectors (expressing SB 
transposase) were also transfected. The results of transfecting pMCS5-PB and 
pMCS5-SB and cotransfection with their corresponding transposases into HEK293 cells 
are shown in Fig 5. 
    
Fig 5: Hematoxylin stained HEK293 cells transfected with vector pMCS5-PB and 
pMCS5-SB as well as pCMV-hyPBase and pC-SB100XN-pA. On display from the 
left: negative control (media and lipofection reagent without added DNA) pMCS5-SB 
Without pC-SB100XN-pA, pMCS5-SB With pC-SB100XN-pA. pMCS5-PB without 
pCMV-hyPBase pMCS5-PB with pCMV-hyPBase. 
 
It is evident from the staining patterns that the PB and SB transposases can mediate 
efficient integration of pMCS5-PB and pMCS5-SB into the genome of HEK293 cells 
based on the presence of a large number of Neomycin resistant cells on the plates into 
which pMCS5-PB and pMCS5-SB had been cotransfected with pCMV-hyPBase and 
pC-SB100XN-pA as compared to the negative control. We also found some neomycin 
resistant colonies growing on the plates in which pMCS5-PB and pMCS5-SB had been 
transfected without their corresponding transposases, indicating that both these vectors 
integrated randomly into the HEK293 cell genome. Although random integration was 
observed the number of neomycin resistant cells present was significantly higher on the 
plates where the vectors were cotransfected with transposase. Hence, this data strongly 
indicate robustness of transposon-mediated integration into host genome. 
 
3.5 Cotransfections of BAC with PiggyBac and sleeping beauty transposase 
To obtain stable transfectants carrying the Prokr2-PB or Prokr2-SB construct, the 
Prokr2-PB BAC vector together with pCMV-hyPBase or Prokr2-SB with 
pC-SB100XN-pA were transfected into HEK293 cells. Following neomycin selection, a 
total of 10 resistant colonies from those cells transfected with the Prokr2-SB and 50 
colonies from the Prokr2-PB transfection were obtained, respectively. Contrary to our 
expectation, the Prokr2-PB vector displayed a detectable level of random integration as 
some neomycin resistant colonies appeared on the plate transfected with Prokr2-PB 
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without PB transposase (see supplemental data). 
 
3.6 Verification of BAC integration into the genome of HEK293 cells 
Out of 50 colonies isolated from the cells transfected with Prokr2-PB 10 colonies were 
chosen for further PCR screening. For Prokr2-SB transfections, the 10 colonies were 
also isolated. The screening was conducted by amplifying several sites in and around 
the reporter GFP gene in order to verify the integrity of the BAC insertion. The results 
can be seen in Fig 6, 7 and 8. 
 
      PB             SB 
 
 
      SB 
 
 
Fig 6: PCR on 20 colonies of which 10 were transfected with Prokr2-PB and the 
remaining 10 with Prokr2-SB. Amplified is a ~450bp amplicon upstream of the GFP 
inserted into Prokr2-PB and Prokr2-SB. Sample order: ladder 2 (supplementary 
material) Prokr2-PB transformed colonies 1-10, Prokr2-SB transformed colonies 1-6. 
Continued on second gel: Prokr2-SB transformed colonies colonies 7-10, negative 
control (human genomic DNA prepared from 293 cells), Positive control (50ng of 
Prokr2-PB DNA), Water, ladder 2 
 
 
 
 
18 
 
     PB      SB 
 
 
         SB 
 
 
 
Fig 7: PCR on 20 colonies of which 10 were transfected with Prokr2-PB and the 
remaining 10 with Prokr2-SB. Amplified is a ~400bp amplicon downstream of the 
NeoR gene of Prokr2-PB and Prokr2-SB. Sample order: ladder 2 Prokr2-PB 
transformed colonies 1-10, Prokr2-SB transformed colonies 1-6. Continued on second 
gel: Prokr2-SB transformed colonies colonies 7-10, negative control (human genomic 
DNA prepared from HEK293 cells), Positive control (50ng of Prokr2-PB DNA), Water, 
ladder 2 
    PB        SB 
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     SB 
 
 
 
Fig 8: PCR on 20 colonies of which 10 were transfected with Prokr2-PB and the 
remaining 10 with Prokr2-SB. Amplified is a ~800bp fragment using a GFP reverse 
primer and a primer located ~500bp upstream of the GFP insertion of Prokr2-PB and 
Prokr2-SB. Sample order: ladder 3 (supplementary material) Prokr2-PB transformed 
colonies 1-10, Prokr2-SB transformed colonies 1-6. Continued on second gel: 
Prokr2-SB transformed colonies colonies 7-10, negative control (human genomic DNA 
prepared from 293 cells), Positive control (2,5ug of DNA), Water, ladder 3. 
 
         PB     SB 
 
 
   SB 
 
 
Fig 9: Internal control PCR of Prokr2-PB and Prokr2-SB transformed HEK293 
cells amplifying a ~800bp amplicon located inside the AAVS1 site on the human 
chromosome. Sample order: ladder 1, Prokr2-PB transformed colonies 1-10, Prokr2-SB 
transformed colonies 1-6. Continued on second gel: ladder 3, Prokr2-SB transformed 
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colonies colonies 7-10, Positive control (human genomic DNA prepared from HEK293 
cells), water.  
 
The internal control PCR confirmed that the absence of bands in some of the wells in 
Fig 6, 7 and 8 was not due to poor quality genomic DNA preparations or DNA 
degradation (see Fig 9). 
 
The results in Fig 9 indicate that all but two genomic DNA preparations were intact 
enough to allow PCR amplification and we concluded that the absence of bands in Fig 6, 
7 and 8 was representative of these BAC elements not having integrated in the genome. 
Based on this we found no intact integration of the region around the eGFP reporter 
gene on Prokr2-PB into the genome of HEK293 cells which is in agreement with the 
results in 3.5 suggesting that Prokr2-PB tends to be integrated randomly into the 
genome. In contrast, we found that at least 5 colonies exhibited successful integration of 
Prokr2-SB as demonstrated by PCR genotyping showing the expected size in well 11, 
12, 16 on the first gel and 1 and 2 on the second gel in Figure 6, 7 and 8. In addition 
Prokr2-SB vector was successfully lipofected into mouse ES cells as indicated by the 
formation of neomycin resistant ES cells although successful integration has yet to be 
verified. 
 
4. Discussion 
This paper reports the generation of a BAC vector containing a reporter GFP gene 
inserted downstream of the start codon of the Prokr2 gene through the use of a 
recombineering strategy using ~450bp of homologous sequences flanking the insert. 
Although sequences shorter than 50bp have been reported to be sufficient to 
successfully perform recombination8, no transformants carrying the 
eGFP-BGHpA-FRT-PGK-neo-FRT insert at the intended location could be isolated in 
our hands (data not shown). Our such recombination experiments resulted in a 
significant amount of kanamycin resistant transformants in which the insert was not 
inserted in the intended location (data not shown) as verified by colony PCR. One 
possible explanation for this false positive colony formation may be due to minor 
contamination of intact eGFP-BGHpA-FRT-PGK-neo-FRT vector from which the 
eGFP-BGHpA-FRT-PGK-neo-FRT fragment was obtained by restriction enzyme 
digestion. This minor contamination would be negligible if recombination efficiency 
would be sufficiently high. We also observed fragmented integration where the clones 
seemed to carry only the kanamycin resistance cassette without the reporter gene as 
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verified by PCR (data not shown). We hypothesized that this was due to insufficient 
targeting by the recombinases and that increasing the sequence homology between the 
insert and the target site would improve recombination accuracy and therefore ~450bp 
of homologous sequences were cloned flanking the eGFP-BGHpA-FRT-PGK-neo-FRT, 
which allowed isolation of a transformant carrying the fragment at the intended location. 
We evaluated whether the BAC vector carrying the reporter construct as well as 
transposable elements were capable of integrating into the genome of HEK293 cells 
using either PB or SB transposase. We found that the BAC reporter carrying SB ITRs 
was successfully integrated by SB transposes, whereas that of PB ITRs showed only a 
limited number of integration. This is in sharp contrast with previous reports where PB 
transposase could mediate efficient insertion8. Although the reason for this discrepancy 
is not clear, it is suggested from our validation study that it is not be due to either 
defects in the ITR elements or the transposase as these were shown to be fully 
functional. In addition，we found that the Prokr2-PB construct also showed a higher 
random integration when compared to the SB vector. The tendency where the PB vector 
shows higher random integration was also noticed during transfections of pMCS5-PB, 
suggesting that the reason for the random integration is not related to the BAC. In 
contrast to the PB-mediated transposition, the SB transposase was found to be able to 
stably integrate the reporter gene construct, eGFP-BGHpA-FRT-PGK-neo-FRT, 
including the surrounding BAC elements as we found that 5 out of 10 colonies of 
HEK293 cells possessed the reporter construct, verified by PCR, indicating a ~50% 
integration frequency. We concluded from this data that the Prokr2-SB vector along with 
SB transposase is capable of integrating into the host genome, suggesting feasibility of 
this system to generate a transgenic mouse ES cell line harboring the a eGFP reporter 
gene under the control of the Prokr2 promoter. 
 
Based on genome-wide transcriptome analysis and subsequent in situ hybridization 
analysis, we found that endogenous Prokr2 is expressed specifically in the dermal 
papilla of mice (data not shown). Hence, the data obtained in this study is of 
considerable interest for future application of the Prokr2 reporter construct to develop a 
system where a transgene of interest is expressed specifically in the dermal papilla. 
Such a transgenesis system could greatly simplify the process of elucidating the 
regulatory mechanisms behind the regulation of hair follicle formation and the hair 
cycle by eliminating transgene expression in surrounding tissues. Future projects 
include verifying if the Prokr2-SB vector is able to stably integrate into mouse 
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embryonic stem (ES) cells followed by implantation of the transgenic cells into a 
pseudo-pregnant mouse, resulting in the birth of a transgenic mouse. This would allow 
determination of the in vivo expression patterns of the Prokr2 gene by observation of 
the fluorescence originating from the reporter gene or histochemical analyses, a project 
which would constitute the final verification as to whether or not the expression of 
Prokr2 truly is dermal papilla specific. If that is the case then the expression system 
presented here could become a valuable tool in order to elucidate the signaling 
pathways regulating the stem cells responsible for the formation of the hair follicle.  
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7. Supplementary material 
7.1 Sequence of eGFP-BGHpA gene 
EGFP-BGHpA  
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCC
ACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACC
GGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGAC
CACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGA
CGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGC
ATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCAT
GGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTC
GCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCA
GTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCA
CTCTCGGCATGGACGAGCTGTACAAGTAAAGCGGCCGCTCGAGCCTCGACTGTGCCTTCTAGTTGCCAGCCATCTGTT
GTTTGCCCCTCCCCCGTGCCTTCCTTGACCCTGGAAGGTGCCACTCCCACTGTCCTTTCCTAATAAAATGAGGAAATTG
CATCGCATTGTCTGAGTAGGTGTCATTCTATTCTGGGGGGTGGGGTGGGGCAGGACAGCAAGGGGGAGGATTGGGAA
GACAATAGCAGGCATGCTGGGGATGCGGTGGGCTCTATGGCTTCTGAGCATAGG  
7.2 Plasmids used in this study 
pBK-CMV 
 
pCMV-hyPBase 
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pC-SB100XN-pA 
 
pR6K-Hyg-Amp-PB 
 
pR6K-Hygro-Spec-SB 
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pROSA26-mT_mG 
 
pSL-Prokr5-EGFP-Pgk-neo-Prokr3 
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pBS-FRT-pgk-neo-FRT 
 
pMCS-PB-FRT-Pgk-Neo-FRT 
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pMCS-SB-FRT-Pgk-Neo-FRT 
 
 
7.3 Primers 
eGFP primers 
SalI (forward) 
AGA GTC GAC TCC CCA GCA TGC CTG CTA TTG TCT TCC 
ApaI (reverse) 
TAC GGG CCC ACC ATG GTG AGC AAG GGC GAG GAG CTG 
Prokr2 homologous 5’ primers: 
Prokr2 SalI (Forward) 
ACC GTC GAC TCG AGA CAG GGT TTC TCT G 
Prokr2 ApaI (Reverse) 
TCT GGG CCC ATG CTA CAG GTG GGC 
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Prokr2 homologous 3’ primers: 
Prokr2 SacII (Forward) 
AGT CCG CGG TTA AAC TAC AGTT TAT GGT G 
Prokr2 HindIII (Reverse) 
TCC AAG CTT TGT GAG AAC TGA AG TGA AC 
Prokr2 Scr 5’ 
CAC TCC CAG CCA CCA ATA CAT TCC CGT CC 
Prokr2 Scr 3’ 
TCA GAG GCT TCC AAC GTC CCC AAA GCT GG 
GFP genotyping (reverse) 
AAG TTC ATC TGC ACC ACC G 
Neomycin genotyping (reverse) 
AAG AAC TCG TCA AGA AGG CGA TAG AAG G 
AAVS5  
CCGGAACTCTGCCCTCTAACGCTGCCGTC  
AAVS13  
GGCCTCCTGGGATACCCCGAAGAGTGAG  
 
 
7.4 PCR protocols 
Colony PCR verification of recombination 
Denaturing 
 (30 sec) 
Annealing 
(30 sec) 
Elongation 
(1,5min) 
Cycles/time 
94   15 min 
94 55 72 25 
  72 7 
 
 
Amplification of ~500bp amplicon upstream of eGFP gene from BAC constructs 
integrated into HEK293 cell genome 
Denaturing 
 (30 sec) 
Annealing 
(30 sec) 
Elongation 
(1,5min) 
Cycles/time 
94   15 min 
94 66 72 35 
  72 7 
Polymerase used: HStaq (takara) 
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Amplification of ~500bp amplicon downstream of neomycin resistance cassette gene 
from BAC constructs integrated into HEK293 cell genome 
Denaturing 
 (30 sec) 
Annealing 
(30 sec) 
Elongation 
(1,5min) 
Cycles/time 
94   15 min 
94 61 72 35 
  72 7 
Polymerase used: HStaq (Takara) 
Amplification of ~800bp amplicon consisting of ~300bp of the eGFP gene and ~ 500bp 
of the upstream region from BAC constructs integrated into HEK293 cell genome 
Denaturing 
 (30 sec) 
Annealing 
(30 sec) 
Elongation 
(1,5min) 
Cycles/time 
94   15 min 
94 55 72 35 
  72 7 
Polymerase used: HStaq (takara) 
 
Internal control PCR on genomic DNA from Prokr2-PB and Prokr2-SB transfected 293 
cells. 
 
Denaturing 
 (10 sec) 
Annealing 
(30 sec) 
Elongation 
(1min) 
Cycles/time 
98   2 min 
98 65 68 2 
98 63 68 2 
98 61 68 2 
98 59 68 2 
98 57 68 2 
98 55 68 20 
  68 7min 
 
Polymerase used: KODFX (Toyobo) 
 
7.5 Sequencing data from eGFP sequencing 
Forward direction 
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Reverse direction 
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7.6 Ladders used in this study 
1 10787-018 1kb plus DNA ladder 
 
2 NEB N0467S Quickload 100bp ladder 
 
3 Nakalai Tesque DNA ladder one 
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7.6 Assessment of random integration of Prokr2-PB and Prokr2-SB in HEK293 
cells 
 
Hematoxylin stained HEK293 cells Transfected with prokr2-PB and Prokr2-SB without 
pCMV-hyPBase and pC-SB100XN-pA. On display from the left: negative control (media 
and lipofection reagent without added DNA), Prokr2-PB, Prokr2-SB 
 
